Ataraxis AI
Ataraxis is an AI precision medicine company focused on oncology, developing AI tools to assist physicians in determining the best treatments for cancer patients. The company collaborates with top academic institutions and clinics to improve cancer care, with a team that includes leading AI researchers and oncologists.
Headquarters
New York, New York, United States
Company Size
1-10 employees
Founded
2023
Ataraxis AI is a pioneering company focused on transforming cancer care through the application of AI precision medicine. Their flagship product, Ataraxis Breast, is the first clinically available AI-native platform specifically designed for breast cancer, utilizing advanced multi-modal tools to enhance treatment selection and improve patient outcomes. The company's technology harnesses cutting-edge artificial intelligence methods to analyze diverse patient data, enabling the identification of novel clinical features that can guide personalized treatment strategies. Ataraxis AI collaborates with leading international cancer centers to refine and implement their groundbreaking solutions in clinical settings.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Ataraxis AI.
86% above the average for this role
Provider Engagement & Partnerships Manager – Germany (Oncology)
Massive Bio, Inc.
Oncology Sales Manager - Tri-Sate - NY/CT/NJ
Sonic Healthcare USA
Radiation Therapist
Grace Federal Solutions LLC
Medical Science Liaison
Natera
Nurse Practitioner or Physician Assistant Oncology Bilingual Mandarin
The Oncology Institute
Clinical Strategy Intern
Ashby